Find Clinical Trials | Cedars-Sinai

155 results found

Lung

LY3537982 and Pembrolizumab vs Placebo and Pembrolizumab in Non-Small Cell Lung Cancer

The purpose of this study is to determine whether the addition of an investigational drug called LY3537982 to the current standard-of-care treatment (immunotherapy +/- chemotherapy) helps control cancer for a longer period of time and ...

Unknown Sites

Newly Diagnosed Very Low-risk and Low-Risk Fusion Negative Rhabdomyosarcoma

This study focuses on people who have been diagnosed with rhabdomyosarcoma (RMS), a type of cancer that occurs in the soft tissues of the body and whose cancer is considered low-risk (LR-RMS). The purpose of ...

Leukemia, other

COG, AALL1821, Ph 3, rando, open-label, relapsed B-ALL, Blinatumomab +/- Nivolumab

Primary: 1. To compare rate of minimal residual disease (MRD) negative second remission (Rem-2, see definition in Section 3.3.3) after up to two cycles of Reinduction with blinatumomab vs. blinatumomab/nivolumab in Group 1 patients aged ? ...

Prostate

High Five Trial: High-Risk Prostate Cancer

The purpose of this study is to compare 2 radiation schedules that can be used to treat patients with high-risk prostate cancer. One approach delivers a higher dose of radiation per treatment and uses fewer ...

Prostate

Urolithin A Supplementation in Men With Prostate Cancer Undergoing Radical Prostatectomy

The purpose of this study is to determine whether an over-the-counter nutritional supplement called Urolithin A changes the biological composition of the prostate in a favorable direction in patients with prostate cancer who are scheduled ...